1. Home
  2. ARVN vs BFLY Comparison

ARVN vs BFLY Comparison

Compare ARVN & BFLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
    SELLHOLDBUYas of 8 hours ago
  • BFLY
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • ARVN 2015
  • BFLY 2011
  • Country
  • ARVN United States
  • BFLY United States
  • Employees
  • ARVN N/A
  • BFLY N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • BFLY Medical Electronics
  • Sector
  • ARVN Health Care
  • BFLY Health Care
  • Exchange
  • ARVN Nasdaq
  • BFLY Nasdaq
  • Market Cap
  • ARVN 1.2B
  • BFLY 1.1B
  • IPO Year
  • ARVN 2018
  • BFLY N/A
  • Fundamental
  • Price
  • ARVN $6.90
  • BFLY $2.12
  • Analyst Decision
  • ARVN Buy
  • BFLY Buy
  • Analyst Count
  • ARVN 13
  • BFLY 1
  • Target Price
  • ARVN $34.42
  • BFLY N/A
  • AVG Volume (30 Days)
  • ARVN 3.6M
  • BFLY 3.3M
  • Earning Date
  • ARVN 05-06-2025
  • BFLY 04-30-2025
  • Dividend Yield
  • ARVN N/A
  • BFLY N/A
  • EPS Growth
  • ARVN N/A
  • BFLY N/A
  • EPS
  • ARVN N/A
  • BFLY N/A
  • Revenue
  • ARVN $263,399,999.00
  • BFLY $82,056,000.00
  • Revenue This Year
  • ARVN N/A
  • BFLY $21.50
  • Revenue Next Year
  • ARVN $7.99
  • BFLY $25.34
  • P/E Ratio
  • ARVN N/A
  • BFLY N/A
  • Revenue Growth
  • ARVN 235.54
  • BFLY 24.52
  • 52 Week Low
  • ARVN $6.75
  • BFLY $0.67
  • 52 Week High
  • ARVN $39.40
  • BFLY $4.98
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 24.13
  • BFLY 31.44
  • Support Level
  • ARVN $8.51
  • BFLY $2.08
  • Resistance Level
  • ARVN $7.36
  • BFLY $2.38
  • Average True Range (ATR)
  • ARVN 0.45
  • BFLY 0.16
  • MACD
  • ARVN 0.08
  • BFLY -0.01
  • Stochastic Oscillator
  • ARVN 6.20
  • BFLY 5.16

Stock Price Comparison Chart: ARVN vs BFLY

ARVN
BFLY
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0102030405060708090100110ARVN VS BFLY

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About BFLY Butterfly Network Inc.

Butterfly Network Inc is a digital health business transforming care with handheld, whole-body ultrasound. Powered by its proprietary Ultrasound-on-Chip technology, its solution enables the acquisition of imaging information from an affordable, powerful device that fits in a healthcare professional's pocket with a combination of cloud-connected software and hardware technology that is easily accessed through a mobile application. Butterfly enables the practical application of ultrasound information in the clinical workflow. Butterfly iQ+ is an ultrasound device that can perform whole-body imaging in a single handheld probe using semiconductor technology. With its small, handheld size, low cost, and simple user interface.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use